Treatment of refractory multiple myeloma and considerations for future therapy

Semin Oncol. 1986 Sep;13(3):326-33.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Alkylating Agents / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Cyclophosphamide / therapeutic use
  • Doxorubicin / therapeutic use
  • Drug Administration Schedule
  • Drug Resistance
  • Humans
  • Melphalan / therapeutic use
  • Multiple Myeloma / drug therapy*
  • Multiple Myeloma / radiotherapy
  • Time Factors

Substances

  • Alkylating Agents
  • Doxorubicin
  • Cyclophosphamide
  • Melphalan